BIO-key International Stock Price, News & Analysis (NASDAQ:BKYI)

$1.37 0.07 (5.38 %)
(As of 12/14/2017 03:45 PM ET)
Previous Close$1.30
Today's Range$1.32 - $1.41
52-Week Range$1.20 - $3.67
Volume13,200 shs
Average Volume13,130 shs
Market Capitalization$10 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.42

About BIO-key International (NASDAQ:BKYI)

BIO-key International, Inc. develops and markets fingerprint biometric identification and identity verification technologies, cryptographic authentication-transaction security technologies, as well as related identity management and credentialing software solutions. The Company is also engaged in developing automated, finger identification technology that supplements or compliments other methods of identification and verification, such as personal inspection identification, passwords, tokens, smart cards, identity cards, public key infrastructure (PKI), credit card, passports, driver's licenses, one-time password (OTP) or other form of possession or knowledge-based credentialing. Its solutions identify individuals and verify, or confirm, their identity before granting access to, among other things, corporate resources, subscribed data and services, Web portals, applications, physical locations or assets.

Receive BKYI News and Ratings via Email

Sign-up to receive the latest news and ratings for BKYI and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Biometric Products
Sub-IndustryN/A
SectorComputer and Technology
SymbolNASDAQ:BKYI
CUSIPN/A
Phone732-359-1100

Debt

Debt-to-Equity RatioN/A
Current Ratio2.93%
Quick Ratio2.42%

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$2.98 million
Price / Sales3.54
Cash FlowN/A
Price / CashN/A
Book Value$2.54 per share
Price / Book0.54

Profitability

Trailing EPSN/A
Net Income$-4,180,000.00
Net Margins-106.55%
Return on Equity-37.54%
Return on Assets-33.31%

Miscellaneous

Employees21
Outstanding Shares7,690,000

BIO-key International (NASDAQ:BKYI) Frequently Asked Questions

What is BIO-key International's stock symbol?

BIO-key International trades on the NASDAQ under the ticker symbol "BKYI."

How were BIO-key International's earnings last quarter?

BIO-key International, Inc. (NASDAQ:BKYI) posted its quarterly earnings data on Tuesday, November, 14th. The technology company reported ($0.28) earnings per share for the quarter, missing the consensus estimate of ($0.17) by $0.11. The technology company earned $0.94 million during the quarter. BIO-key International had a negative net margin of 106.55% and a negative return on equity of 37.54%. View BIO-key International's Earnings History.

When will BIO-key International make its next earnings announcement?

BIO-key International is scheduled to release their next quarterly earnings announcement on Friday, March, 30th 2018. View Earnings Estimates for BIO-key International.

Where is BIO-key International's stock going? Where will BIO-key International's stock price be in 2017?

1 analysts have issued 12 month price targets for BIO-key International's shares. Their forecasts range from $5.50 to $5.50. On average, they anticipate BIO-key International's share price to reach $5.50 in the next twelve months. View Analyst Ratings for BIO-key International.

Who are some of BIO-key International's key competitors?

Who are BIO-key International's key executives?

BIO-key International's management team includes the folowing people:

  • Michael W. DePasquale, Chairman of the Board, Chief Executive Officer (Age 60)
  • Cecilia C Welch, Chief Financial Officer (Age 56)
  • Barbara Rivera, Chief Operating Officer, Director (Age 64)
  • Scott Mahnken, Vice President - Marketing (Age 55)
  • Mira K LaCous, Vice President - Technology and Development (Age 54)
  • Renat Zhdanov, Chief Scientist (Age 52)
  • Thomas E Bush III, Director (Age 63)
  • Thomas Gilley, Director (Age 54)
  • Pieter Cornelis Knook, Director (Age 59)
  • Robert J. Michel CPA, Director (Age 60)

Who owns BIO-key International stock?

BIO-key International's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Commonwealth Equity Services Inc (1.22%). View Institutional Ownership Trends for BIO-key International.

Who bought BIO-key International stock? Who is buying BIO-key International stock?

BIO-key International's stock was bought by a variety of institutional investors in the last quarter, including Commonwealth Equity Services Inc. View Insider Buying and Selling for BIO-key International.

How do I buy BIO-key International stock?

Shares of BIO-key International can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is BIO-key International's stock price today?

One share of BIO-key International stock can currently be purchased for approximately $1.37.

How big of a company is BIO-key International?

BIO-key International has a market capitalization of $10 million and generates $2.98 million in revenue each year. BIO-key International employs 21 workers across the globe.

How can I contact BIO-key International?

BIO-key International's mailing address is 3349 HIGHWAY 138 BUILDING A SUITE E, WALL TOWNSHIP NJ, 07719. The technology company can be reached via phone at 732-359-1100 or via email at [email protected]


MarketBeat Community Rating for BIO-key International (BKYI)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  29 (Vote Outperform)
Underperform Votes:  23 (Vote Underperform)
Total Votes:  52
MarketBeat's community ratings are surveys of what our community members think about BIO-key International and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

BIO-key International (NASDAQ:BKYI) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyN/A
Consensus Rating Score: 3.003.003.00N/A
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $5.50$5.50$5.50N/A
Price Target Upside: 89.66% upside89.66% upside89.66% upsideN/A

BIO-key International (NASDAQ:BKYI) Consensus Price Target History

Price Target History for BIO-key International (NASDAQ:BKYI)

BIO-key International (NASDAQ:BKYI) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
7/13/2017Maxim GroupInitiated CoverageBuy -> Buy$5.50N/AView Rating Details
(Data available from 12/14/2015 forward)

Earnings

BIO-key International (NASDAQ:BKYI) Earnings History and Estimates Chart

Earnings by Quarter for BIO-key International (NASDAQ:BKYI)

BIO-key International (NASDAQ BKYI) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/30/2018        
11/14/2017Q3 2017($0.17)($0.28)$0.94 millionViewN/AView Earnings Details
8/14/2017Q2 2017($0.22)($0.32)$0.89 millionViewN/AView Earnings Details
5/15/2017Q1 2017($0.26)$1.42 millionViewN/AView Earnings Details
8/15/2016Q2($0.02)$0.42 millionViewN/AView Earnings Details
5/16/2016Q1($0.02)$0.43 millionViewListenView Earnings Details
3/30/2016Q4($0.01)$1.67 millionViewListenView Earnings Details
8/14/2015Q2 2015$0.01$2.27 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

BIO-key International (NASDAQ:BKYI) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for BIO-key International (NASDAQ:BKYI)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

BIO-key International (NASDAQ BKYI) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 11.40%
Institutional Ownership Percentage: 2.93%
Insider Trades by Quarter for BIO-key International (NASDAQ:BKYI)

BIO-key International (NASDAQ BKYI) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/22/2017Fong Wong KwokInsiderBuy427,778$3.60$1,540,000.80View SEC Filing  
8/31/2017Fong Wong KwokInsiderBuy26,300$3.10$81,530.00View SEC Filing  
4/28/2017Fong Wong KwokInsiderBuy277,778$3.60$1,000,000.80View SEC Filing  
11/18/2016Fong Wong KwokDirectorBuy6,200,000$0.30$1,860,000.00View SEC Filing  
9/16/2016Fong Wong KwokDirectorBuy651,500$0.25$162,875.00View SEC Filing  
9/15/2016Fong Wong KwokDirectorBuy925,200$0.25$231,300.00View SEC Filing  
9/13/2016Fong Wong KwokDirectorBuy841,975$0.24$202,074.00View SEC Filing  
6/15/2016Fong Wong KwokDirectorBuy172,000$0.28$48,160.00View SEC Filing  
6/13/2016Fong Wong KwokDirectorBuy786,900$0.29$228,201.00View SEC Filing  
6/10/2016Fong Wong KwokDirectorBuy428,100$0.28$119,868.00View SEC Filing  
6/9/2016Fong Wong KwokDirectorBuy712,100$0.26$185,146.00View SEC Filing  
6/7/2016Fong Wong KwokDirectorBuy565,712$0.23$130,113.76View SEC Filing  
6/2/2016Fong Wong KwokDirectorBuy696,038$0.22$153,128.36View SEC Filing  
6/1/2016Fong Wong KwokDirectorBuy190,605$0.18$34,308.90View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

BIO-key International (NASDAQ BKYI) News Headlines

Source:

SEC Filings

BIO-key International (NASDAQ:BKYI) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

BIO-key International (NASDAQ:BKYI) Income Statement, Balance Sheet and Cash Flow Statement

Chart

BIO-key International (NASDAQ BKYI) Stock Chart for Thursday, December, 14, 2017

Loading chart…

This page was last updated on 12/14/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.